Your browser doesn't support javascript.
loading
Clostridium perfringens virulence factors are nonredundant activators of the NLRP3 inflammasome.
Mathur, Anukriti; Kay, Callum; Xue, Yansong; Pandey, Abhimanu; Lee, Jiwon; Jing, Weidong; Enosi Tuipulotu, Daniel; Lo Pilato, Jordan; Feng, Shouya; Ngo, Chinh; Zhao, Anyang; Shen, Cheng; Rug, Melanie; Miosge, Lisa A; Atmosukarto, Ines I; Price, Jason D; Ali, Sidra A; Gardiner, Elizabeth E; Robertson, Avril Ab; Awad, Milena M; Lyras, Dena; Kaakoush, Nadeem O; Man, Si Ming.
Affiliation
  • Mathur A; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Kay C; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Xue Y; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Pandey A; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Lee J; Centre for Advanced Microscopy, The Australian National University, Canberra, ACT, Australia.
  • Jing W; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Enosi Tuipulotu D; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Lo Pilato J; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Feng S; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Ngo C; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Zhao A; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Shen C; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Rug M; Centre for Advanced Microscopy, The Australian National University, Canberra, ACT, Australia.
  • Miosge LA; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Atmosukarto II; Lipotek Pty Ltd. The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Price JD; Lipotek Pty Ltd. The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Ali SA; Division of Genome Science and Cancer, The Australian National University, Canberra, ACT, Australia.
  • Gardiner EE; Division of Genome Science and Cancer, The Australian National University, Canberra, ACT, Australia.
  • Robertson AA; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
  • Awad MM; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, VIC, Australia.
  • Lyras D; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, VIC, Australia.
  • Kaakoush NO; School of Medical Sciences, UNSW Sydney, Sydney, NSW, Australia.
  • Man SM; Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
EMBO Rep ; 24(6): e54600, 2023 06 05.
Article in En | MEDLINE | ID: mdl-37073791
Inflammasome signaling is a central pillar of innate immunity triggering inflammation and cell death in response to microbes and danger signals. Here, we show that two virulence factors from the human bacterial pathogen Clostridium perfringens are nonredundant activators of the NLRP3 inflammasome in mice and humans. C. perfringens lecithinase (also known as phospolipase C) and C. perfringens perfringolysin O induce distinct mechanisms of activation. Lecithinase enters LAMP1+ vesicular structures and induces lysosomal membrane destabilization. Furthermore, lecithinase induces the release of the inflammasome-dependent cytokines IL-1ß and IL-18, and the induction of cell death independently of the pore-forming proteins gasdermin D, MLKL and the cell death effector protein ninjurin-1 or NINJ1. We also show that lecithinase triggers inflammation via the NLRP3 inflammasome in vivo and that pharmacological blockade of NLRP3 using MCC950 partially prevents lecithinase-induced lethality. Together, these findings reveal that lecithinase activates an alternative pathway to induce inflammation during C. perfringens infection and that this mode of action can be similarly exploited for sensing by a single inflammasome.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammasomes / NLR Family, Pyrin Domain-Containing 3 Protein Limits: Animals / Humans Language: En Journal: EMBO Rep Journal subject: BIOLOGIA MOLECULAR Year: 2023 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammasomes / NLR Family, Pyrin Domain-Containing 3 Protein Limits: Animals / Humans Language: En Journal: EMBO Rep Journal subject: BIOLOGIA MOLECULAR Year: 2023 Type: Article Affiliation country: Australia